Funding for this research was provided by:
European Research Council (ERC-2013-ADG-341196)
H2020 Future and Emerging Technologies (641321H2020-FETPROACT-2014)
Ministerio de Economia y Empresa (TIN2013-44200-R)
EIT Health (RGS@Home) under H2020 (19277)
Text and Data Mining valid from 2020-03-06
Received: 10 July 2019
Accepted: 28 January 2020
First Online: 6 March 2020
Ethics approval and consent to participate
: This randomized controlled pilot trial was approved by the local Ethical Committee at Parc de Salut Mar, and all eligible patients enrolled in the study gave their written consent to participate. No patient without consent participated in this trial.
: Not applicable.
: The authors declare the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: PFMJV is the founder and interim CEO of Eodyne S L, which aims at bringing scientifically validated neurorehabilitation technology to society. The rest of the authors have nothing to disclose.